To: Cacaito who wrote (2265 ) 5/23/1998 5:54:00 PM From: max Respond to of 5736
Cacaito-You make several statements of "fact" in your recent posts. Lets address the factual reality of some of them: <<But, most pediatricians will not need the Colormate>> What is the source of this statement? Every pediatrician I've spoken with will absolutely have at least one on hand. Its a no brainer, because it allows them to monitor newborns under their care at the office, or at the infant's home, avoiding continual trips to the hospital. <<SPRX will compete again CCSI in the near future in the USA.>> How do you figure? They haven't even completed clinical trials, let alone submitted to the FDA for what will surely be a lengthy approval process. Besides that, reports are that it doesn't work on all races, and most significantly, doesn't work during therapy. Now tell me:What good is it if you can't monitor the effectiveness of the therapy? SPRX is a joke, and anyone who claims otherwise will have a most difficult time establishing credibility. <<SPRX is shipping product to the international market (or they are not telling the truth in their press releases).>> They may be shipping product. How many? 1? 10? 100? 1000? Funny, they don't mention any numbers. Is anyone actually using it? Their underwriters aren't too impressed, they've done nothing but sell stock since the New Orleans conference. << I did forgot to included the disposables in my now infamous "business model">> Interesting ommision, the disposable is the key to the continued revenue stream. <<Manfred, there will be at best 10% of pediatricians buying the Colormate. Home Health Care will not buy the Colormate.>> Interesting assertions. And where did you come up with this? Pediatricians most definitely want this device, and no parent with a jaundiced infant would consider going home without one. That much is rather obvious. <<The disposables costs will limit the use of the Colormate.>> Again, how do you figure? Your logic escapes me. For one thing, you don't have a clue how much the disposables will cost. For another, insurance will be paying the costs, as the CCSI device has been approved for reimbursement in all 50 states. And contrary to your statement on the SPRX thread: <<Patient bill expenses will be covered by insurance companies for both (very important). >> SPRX has most definitely NOT been approved for reimbursement anywhere in the USA. They haven't even completed clinical trials for FDA submission, let alone gotten FDA approval, which would obviously be required prior to any insurance coverage. Where on Earth do you come up with this nonsense? Back to the disposables. Do you actually believe that an insurance company would rather take a preemie's blood and send it to a lab for analysis when the simple use of CCSI's device with the disposable is available. By the way, part of the FDA approval requires the replacement of the calibration device (the "disposable") with each test. This is for the purpose of calibration, as the name implies, of skin color, as well as for sterility. <<There is very, very little use for the Colormate beyond one week of life>> Currently correct. Which is why its being marketed as a device to measure "infant" bilirubin, and all of the credible earnings models account for this. You appear to know a lot. I believe you know nothing. Perhaps you could post verifiable credentials before your next series of unqualified statements of "fact".